A Pooled Analysis of 25-hydroxyvitamin D and Colorectal Cancer Survival
A Pooled Analysis of 25-hydroxyvitamin D and Colorectal Cancer Survival
批准号:
8773987
负责人:
Veronika Fedirko
金额:
$9.34万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-07-01 至 2016-06-30
关键词:
25-hydroxyvitamin DAdoptedAffectAndrogen ReceptorAnimalsAsiaBasic ScienceBiologicalBiological MarkersBloodBody mass indexCancer EtiologyCancer PatientCancer SurvivorCell CycleCessation of lifeCharacteristicsChemopreventionChemopreventive AgentCohort EffectCohort StudiesCollectionColonColon CarcinomaColonic NeoplasmsColorectal CancerCoupledDataData ProtectionDevelopmentDiagnosisDiagnosticDietDietary CalciumDietary FactorsDiseaseEarly DiagnosisEarly treatmentEpidemiologic StudiesEstrogen ReceptorsEuropeFundingFutureGenetic PolymorphismGenetic VariationGoalsGrowth FactorHabitsHumanIncidenceInflammationInvestigationLaboratoriesLeadLifeLife StyleMeasuresMeta-AnalysisNeoplasm MetastasisOutcomeOxidative StressParentsPathway interactionsPatientsPersonsPhysical activityPopulationPreventionProspective StudiesPublishingQuality of lifeRandomized Clinical TrialsRandomized Controlled TrialsReceptor GeneRectal CancerRecurrenceReportingResourcesRiskRisk FactorsSeasonsSignal TransductionSiteSmokingStagingSubgroupSupplementationSurvival AnalysisTreatment EffectivenessTreatment ProtocolsTumor SubtypeVitamin DVitamin D3 ReceptorVitaminsadverse outcomeangiogenesisanticancer treatmentbasecalcium intakecancer diagnosiscancer recurrencecancer riskcancer sitecancer therapycohortcolorectal cancer screeningcost effectiveimmune functionimprovedinsightlifestyle factorsmalignant breast neoplasmmodifiable riskmortalityparent grantpreventprospectivepublic health relevancescreeningsextertiary preventiontime intervaltumortumor progression
中文摘要
描述(由申请人提供):尽管在预防、筛查、早期发现和治疗方面取得了进展,但结直肠癌(CRC)仍然是美国第三大最常诊断的癌症和第二大癌症死亡原因,预计2013年约有142,820例新病例和50,830例死亡。尽管CRC早期发现和治疗的进展导致了相对较长的生存期,但可改变的饮食和生活方式因素可能对生存有影响的研究尚未得到充分探讨。维生素D是一种潜在的化学预防CRC患者癌症进展、复发和死亡的药物,可能通过其直接影响细胞周期、调节生长因子信号、雌激素和雄激素受体途径、炎症、氧化应激和免疫功能,以及抑制侵袭、转移和血管生成的机制。较高的循环维生素D水平始终与较低的结直肠癌风险相关,但它们与结直肠癌存活率的关系相对未被探索。基于基础科学和有限的人类证据,我们假设较高水平的前瞻性收集,诊断前循环维生素D [25(OH)D,维生素D状态的最佳指标]与CRC病例中较低的CRC特异性和总体死亡率相关。我们将在正在进行的nci资助的(R01 CA152071)乳腺癌和结直肠癌维生素D汇集项目(VDPP)的一项辅助研究中研究这一点,该项目汇集了来自美国、欧洲和亚洲的21项前瞻性队列研究的综合原始数据,以调查25(OH)D水平与这些癌症部位的总体风险之间的关系,按肿瘤亚型和按个人特征、生活方式因素、维生素D受体(VDR)多态性定义的人群亚组,以及其他生物标志物。我们将分析(使用传统和竞争风险生存分析)诊断前25(OH) D水平与在美国、欧洲和亚洲进行的16项队列研究中5,795例CRC病例(其中有2,627例死亡)的CRC特异性和总体死亡率风险之间的关系。作为父母资助的一部分,25(OH)D水平已被校准到一个共同的标准实验室,以便不仅使用研究特定的五分位数,而且还使用整个联盟的五分位数和共同的绝对切点对25(OH)D水平进行分类。这项辅助研究提供了一个独特的、具有成本效益和资源效率的机会,是目前最大的汇总研究,旨在调查诊断前25(OH)D水平与crc特异性和总体死亡率之间的关系,特别强调潜在的生活方式(体重指数、身体活动、钙摄入量)和遗传(VDR的变异)
英文摘要
DESCRIPTION (provided by applicant): Despite advances in prevention, screening, early detection, and treatment, colorectal cancer (CRC) remains the 3rd most commonly diagnosed cancer and the 2nd leading cause of cancer death in the US, with approximately 142,820 new cases and 50,830 deaths expected in 2013. Although advances in CRC early detection and treatment have resulted in relatively longer survival, the impact of modifiable dietary and lifestye factors that may contribute to survival has not been sufficiently explored. Vitamin D is a potentia agent for the chemoprevention of cancer progression, recurrence and death in CRC patients, possibly through mechanisms related to its direct effects on the cell cycle, modulation of growth factor signaling, estrogen and androgen receptor pathways, inflammation, oxidative stress, and immune function, as well as inhibition of invasion, metastasis, and angiogenesis. Higher circulating vitamin D levels are consistently associated with lower risk for CRC, but their association with CRC survival is relatively unexplored. Based on basic science and limited human evidence, we hypothesize that higher levels of prospectively collected, pre-diagnostic circulating vitamin D [25(OH)D, the best indicator of vitamin D status] are associated with lower CRC-specific and overall mortality among CRC cases. We will investigate this in an adjunct study to the ongoing, NCI-funded (R01 CA152071) Vitamin D Pooling Project of Breast and Colorectal Cancer (VDPP), which pools comprehensive primary data from 21 prospective cohort studies from the US, Europe, and Asia to investigate associations between 25(OH)D levels and risk of these cancer sites overall, by tumor subtype, and by population subgroups defined by personal characteristics, lifestyle factors, vitamin D receptor (VDR) polymorphisms, and other biomarkers. We will analyze (using traditional and competing risk survival analyses) the association between pre-diagnostic 25(OH) D levels and risk of CRC-specific and overall mortality in 5,795 CRC cases (among which there were 2,627 deaths) in 16 cohort studies conducted in the US, Europe, and Asia. As part of the parent grant, the 25(OH) D levels have been calibrated to a common standard laboratory to enable categorization of 25(OH)D levels using not only study-specific quintiles, but also consortium-wide quintiles and common absolute cut points. This adjunct study offers a unique, cost-effective and resource-efficient opportunity i the largest pooled study currently available to investigate an association between pre-diagnostic 25(OH)D levels and CRC-specific and overall mortality, with particular emphasis on potential lifestyle (body mass index, physical activity, calcium intake) and genetic (variation in the VDR in
a sub-set of cohorts) effect modifiers, and examine the effects of vitamin D on CRC survival by colon sub-site, sex, and tumor characteristics. This study will provide an important step forward in understanding whether vitamin D affects CRC progression and survival, as well as insight into the potential application of this important compound in CRC treatment regimens.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The Role of the Gut Microbiome and Short Chain Fatty Acids in the Regulation of Inflammation and Neuropsychological Symptoms in Patients with Head and Neck Cancer
-
批准号:10619515
-
项目类别:
-
资助金额:$76.46万
-
财政年份:2022
-
负责人:Veronika Fedirko
-
依托单位:
The Role of the Gut Microbiome and Short Chain Fatty Acids in the Regulation of Inflammation and Neuropsychological Symptoms in Patients with Head and Neck Cancer
-
批准号:10344486
-
项目类别:
-
资助金额:$79.76万
-
财政年份:2022
-
负责人:Veronika Fedirko
-
依托单位:
Gut Microbiome, Antibiotic Use & Colon Cancer Recurrence
-
批准号:9384255
-
项目类别:
-
资助金额:$55.01万
-
财政年份:2017
-
负责人:Veronika Fedirko
-
依托单位:
Gut Microbiome, Antibiotic Use & Colon Cancer Recurrence
-
批准号:9751802
-
项目类别:
-
资助金额:$49.7万
-
财政年份:2017
-
负责人:Veronika Fedirko
-
依托单位:
Gut Microbiome, Antibiotic Use & Colon Cancer Recurrence
-
批准号:10226249
-
项目类别:
-
资助金额:$44.61万
-
财政年份:2017
-
负责人:Veronika Fedirko
-
依托单位:
Vitamin D3, Calcium and Inflammation, Immunomodulation and Colonic Permeability
-
批准号:8828139
-
项目类别:
-
资助金额:$8.17万
-
财政年份:2014
-
负责人:Veronika Fedirko
-
依托单位:
Vitamin D3, Calcium and Inflammation, Immunomodulation and Colonic Permeability
-
批准号:8684361
-
项目类别:
-
资助金额:$8.95万
-
财政年份:2014
-
负责人:Veronika Fedirko
-
依托单位:
Vitamin D3, Calcium and Biomarkers of Gut Barrier Function
-
批准号:8755182
-
项目类别:
-
资助金额:$21.61万
-
财政年份:2014
-
负责人:Veronika Fedirko
-
依托单位:
海外基金